These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27022468)

  • 1. Inhaled loxapine and intramuscular lorazepam in healthy volunteers: a randomized placebo-controlled drug-drug interaction study.
    Spyker DA; Cassella JV; Stoltz RR; Yeung PP
    Pharmacol Res Perspect; 2015 Dec; 3(6):e00194. PubMed ID: 27022468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, placebo-controlled repeat-dose thorough QT study of inhaled loxapine in healthy volunteers.
    Cassella JV; Spyker DA; Yeung PP
    Int J Clin Pharmacol Ther; 2015 Nov; 53(11):963-71. PubMed ID: 26501204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo-controlled clinical trial with inhaled loxapine.
    Kwentus J; Riesenberg RA; Marandi M; Manning RA; Allen MH; Fishman RS; Spyker DA; Kehne JH; Cassella JV
    Bipolar Disord; 2012 Feb; 14(1):31-40. PubMed ID: 22329470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, placebo-controlled repeat-dose thorough QT study of inhaled loxapine in healthy volunteers.
    Cassella JV; Spyker DA; Yeung PP
    Int J Clin Pharmacol Ther; 2015 Oct; ():. PubMed ID: 26445139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PLACID study: A randomized trial comparing the efficacy and safety of inhaled loxapine versus intramuscular aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder.
    San L; Estrada G; Oudovenko N; Montañés F; Dobrovolskaya N; Bukhanovskaya O; Popov M; Vieta E
    Eur Neuropsychopharmacol; 2018 Jun; 28(6):710-718. PubMed ID: 29724638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled loxapine for agitation revisited: focus on effect sizes from 2 Phase III randomised controlled trials in persons with schizophrenia or bipolar disorder.
    Citrome L
    Int J Clin Pract; 2012 Mar; 66(3):318-25. PubMed ID: 22226343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aerosolised antipsychotic assuages agitation: inhaled loxapine for agitation associated with schizophrenia or bipolar disorder.
    Citrome L
    Int J Clin Pract; 2011 Mar; 65(3):330-40. PubMed ID: 21199198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and design of the PLACID study: a randomised trial comparing the efficacy and safety of inhaled loxapine versus IM aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder.
    San L; Estrada G; Oudovenko N; Vieta E
    BMC Psychiatry; 2017 Apr; 17(1):126. PubMed ID: 28376877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial.
    Allen MH; Feifel D; Lesem MD; Zimbroff DL; Ross R; Munzar P; Spyker DA; Cassella JV
    J Clin Psychiatry; 2011 Oct; 72(10):1313-21. PubMed ID: 21294997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine.
    Lesem MD; Tran-Johnson TK; Riesenberg RA; Feifel D; Allen MH; Fishman R; Spyker DA; Kehne JH; Cassella JV
    Br J Psychiatry; 2011 Jan; 198(1):51-8. PubMed ID: 21200077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple dose pharmacokinetics of inhaled loxapine in subjects on chronic, stable antipsychotic regimens.
    Spyker DA; Riesenberg RA; Cassella JV
    J Clin Pharmacol; 2015 Sep; 55(9):985-94. PubMed ID: 25808074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addressing the need for rapid treatment of agitation in schizophrenia and bipolar disorder: focus on inhaled loxapine as an alternative to injectable agents.
    Citrome L
    Ther Clin Risk Manag; 2013; 9():235-45. PubMed ID: 23723707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loxapine inhalation powder: a review of its use in the acute treatment of agitation in patients with bipolar disorder or schizophrenia.
    Keating GM
    CNS Drugs; 2013 Jun; 27(6):479-89. PubMed ID: 23740380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of self-administered inhaled loxapine (ADASUVE) in agitated patients outside the hospital setting: protocol for a phase IV, single-arm, open-label trial.
    Gil E; Garcia-Alonso F; Boldeanu A; Baleeiro Teixeira T;
    BMJ Open; 2018 Oct; 8(10):e020242. PubMed ID: 30282677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of loxapine following inhalation of a thermally generated aerosol in healthy volunteers.
    Spyker DA; Munzar P; Cassella JV
    J Clin Pharmacol; 2010 Feb; 50(2):169-79. PubMed ID: 19915181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loxapine delivered as a thermally generated aerosol does not prolong QTc in a thorough QT/QTc study in healthy subjects.
    Spyker DA; Voloshko P; Heyman ER; Cassella JV
    J Clin Pharmacol; 2014 Jun; 54(6):665-74. PubMed ID: 24375070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examining the safety, efficacy, and patient acceptability of inhaled loxapine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults.
    Faden J; Citrome L
    Neuropsychiatr Dis Treat; 2019; 15():2273-2283. PubMed ID: 31496709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Mirogabalin When Coadministered With Lorazepam, Zolpidem, Tramadol, or Ethanol: Results From Drug-Drug Interaction Studies in Healthy Subjects.
    Jansen M; Mendell J; Currie A; Dow J; He L; Merante D; Dishy V; Ishizuka H; Zahir H
    Clin Pharmacol Drug Dev; 2018 Aug; 7(6):597-612. PubMed ID: 29870596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic-pharmacodynamic interaction between nebicapone and controlled-release levodopa/benserazide: a single-center, Phase I, double-blind, randomized, placebo-controlled, four-way crossover study in healthy subjects.
    Nunes T; Machado R; Rocha JF; Fernandes-Lopes C; Costa R; Torrão L; Loureiro AI; Falcão A; Vaz-da-Silva M; Wright L; Almeida L; Soares-da-Silva P
    Clin Ther; 2009 Oct; 31(10):2258-71. PubMed ID: 19922897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Now take a deep breath: inhaled loxapine for the treatment of acute agitation.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2012 Jan; 50(1):16-8. PubMed ID: 22229963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.